Nanofibers of N,N,N-trimethyl chitosan capped bimetallic nanoparticles : Preparation, characterization, wound dressing and in vivo treatment of MDR microbial infection and tracking by optical and photoacoustic imaging
Copyright © 2024 Elsevier B.V. All rights reserved..
Recent advancements in wound care have led to the development of interactive wound dressings utilizing nanotechnology, aimed at enhancing healing and combating bacterial infections while adhering to established protocols. Our novel wound dressings consist of N,N,N-trimethyl chitosan capped gold‑silver nanoparticles (Au-Ag-TMC-NPs), with a mean size of 108.3 ± 8.4 nm and a zeta potential of +54.4 ± 1.8 mV. These optimized nanoparticles exhibit potent antibacterial and antifungal properties, with minimum inhibitory concentrations ranging from 0.390 μg ml-1 to 3.125 μg ml-1 and also exhibited promising zones of inhibition against multi-drug resistant strains of S. aureus, E. coli, P. aeruginosa, and C. albicans. Microbial transmission electron microscopy reveals substantial damage to cell walls and DNA condensation post-treatment. Furthermore, the nanoparticles demonstrate remarkable inhibition of microbial efflux pumps and are non-hemolytic in human blood. Incorporated into polyvinyl alcohol/chitosan nanofibers, they form Au-Ag-TMC-NPs-NFs with diameters of 100-350 nm, facilitating efficient antimicrobial wound dressing. In vivo studies on MDR microbial-infected wounds in mice showed 99.34 % wound healing rate within 12 days, corroborated by analyses of wound marker protein expression levels and advanced imaging techniques such as ultrasound/photoacoustic imaging, providing real-time visualization and blood flow assessment for a comprehensive understanding of the dynamic wound healing processes.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:263 |
---|---|
Enthalten in: |
International journal of biological macromolecules - 263(2024), Pt 1 vom: 25. März, Seite 130154 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Malik, Ankit Kumar [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 27.03.2024 Date Revised 27.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.ijbiomac.2024.130154 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM368450341 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM368450341 | ||
003 | DE-627 | ||
005 | 20240327235815.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240215s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ijbiomac.2024.130154 |2 doi | |
028 | 5 | 2 | |a pubmed24n1351.xml |
035 | |a (DE-627)NLM368450341 | ||
035 | |a (NLM)38354928 | ||
035 | |a (PII)S0141-8130(24)00957-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Malik, Ankit Kumar |e verfasserin |4 aut | |
245 | 1 | 0 | |a Nanofibers of N,N,N-trimethyl chitosan capped bimetallic nanoparticles |b Preparation, characterization, wound dressing and in vivo treatment of MDR microbial infection and tracking by optical and photoacoustic imaging |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 27.03.2024 | ||
500 | |a Date Revised 27.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2024 Elsevier B.V. All rights reserved. | ||
520 | |a Recent advancements in wound care have led to the development of interactive wound dressings utilizing nanotechnology, aimed at enhancing healing and combating bacterial infections while adhering to established protocols. Our novel wound dressings consist of N,N,N-trimethyl chitosan capped gold‑silver nanoparticles (Au-Ag-TMC-NPs), with a mean size of 108.3 ± 8.4 nm and a zeta potential of +54.4 ± 1.8 mV. These optimized nanoparticles exhibit potent antibacterial and antifungal properties, with minimum inhibitory concentrations ranging from 0.390 μg ml-1 to 3.125 μg ml-1 and also exhibited promising zones of inhibition against multi-drug resistant strains of S. aureus, E. coli, P. aeruginosa, and C. albicans. Microbial transmission electron microscopy reveals substantial damage to cell walls and DNA condensation post-treatment. Furthermore, the nanoparticles demonstrate remarkable inhibition of microbial efflux pumps and are non-hemolytic in human blood. Incorporated into polyvinyl alcohol/chitosan nanofibers, they form Au-Ag-TMC-NPs-NFs with diameters of 100-350 nm, facilitating efficient antimicrobial wound dressing. In vivo studies on MDR microbial-infected wounds in mice showed 99.34 % wound healing rate within 12 days, corroborated by analyses of wound marker protein expression levels and advanced imaging techniques such as ultrasound/photoacoustic imaging, providing real-time visualization and blood flow assessment for a comprehensive understanding of the dynamic wound healing processes | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Antimicrobial resistance | |
650 | 4 | |a Bimetallic nanoparticles-nanofibers | |
650 | 4 | |a Photoacoustic imaging | |
650 | 4 | |a Pseudomonas aeruginosa | |
650 | 4 | |a Trimethyl chitosan | |
650 | 4 | |a Wound dressing | |
650 | 7 | |a N-trimethyl chitosan chloride |2 NLM | |
650 | 7 | |a Chitosan |2 NLM | |
650 | 7 | |a 9012-76-4 |2 NLM | |
650 | 7 | |a Silver |2 NLM | |
650 | 7 | |a 3M4G523W1G |2 NLM | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
700 | 1 | |a Singh, Chandrashekhar |e verfasserin |4 aut | |
700 | 1 | |a Tiwari, Punit |e verfasserin |4 aut | |
700 | 1 | |a Verma, Dipti |e verfasserin |4 aut | |
700 | 1 | |a Mehata, Abhishesh Kumar |e verfasserin |4 aut | |
700 | 1 | |a Vikas |e verfasserin |4 aut | |
700 | 1 | |a Setia, Aseem |e verfasserin |4 aut | |
700 | 1 | |a Mukherjee, Ashim |e verfasserin |4 aut | |
700 | 1 | |a Muthu, Madaswamy S |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal of biological macromolecules |d 1992 |g 263(2024), Pt 1 vom: 25. März, Seite 130154 |w (DE-627)NLM012627356 |x 1879-0003 |7 nnns |
773 | 1 | 8 | |g volume:263 |g year:2024 |g number:Pt 1 |g day:25 |g month:03 |g pages:130154 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ijbiomac.2024.130154 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 263 |j 2024 |e Pt 1 |b 25 |c 03 |h 130154 |